NRX Pharmaceuticals (NRXP) Q1 2023 Earnings

16MayConfirmed
Aug 22
Q3 2022
Q4 2022
Q1 2023
-0.16
-0.14
-0.12
-0.1

Details

Expected EPS
-0.14
Actual EPS
-0.16
Surprise EPS
-0.02
Surprise Percent
+14.29%

Description

NRX Pharmaceuticals (NRXP) has reported earnings of -0.16 per share for Q1 2023.

0 Comments

Share your thoughts